Quantitative structure-pharmacokinetic relationship modelling: Apparent volume of distribution

Journal of Pharmacy and Pharmacology

Volumn 56, Issue 3, 2004, Pages 339-350

  Ghafourian, Taravat ^a,b   Barzegar Jalali, Mohammad ^a   Hakimiha, Nasim ^a   Cronin, Mark T D ^b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETANILIDE; ALPRAZOLAM; AMFEBUTAMONE; ANESTHETIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BROMAZEPAM; BUPIVACAINE; CARBAMAZEPINE; CENTRAL NERVOUS SYSTEM AGENTS; CHLORAL HYDRATE; CHLORDIAZEPOXIDE; CHLORPHENTERMINE; CLOBAZAM; CLOMIPRAMINE; CLONAZEPAM; CLORAZEPATE; DESIPRAMINE; DOXEPIN; ETHCHLORVYNOL; FLUOXETINE; GLUTETHIMIDE; HALOPERIDOL; HYDANTOIN DERIVATIVE; IMIPRAMINE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; SUCCINIMIDE DERIVATIVE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ACIDITY; ANALYTICAL ERROR; ARTICLE; CONTROLLED STUDY; DISTRIBUTION VOLUME; DRUG DETERMINATION; DRUG PROTEIN BINDING; DRUG STRUCTURE; PARTITION COEFFICIENT; PH MEASUREMENT; PHYSICAL CHEMISTRY; PREDICTION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REGRESSION ANALYSIS; STATISTICAL MODEL; VALIDATION PROCESS;

ALGORITHMS; HUMANS; HYDROGEN-ION CONCENTRATION; MODELS, BIOLOGICAL; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; PROTEIN BINDING; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 1642306443     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357022890     Document Type: Article

References (50)

1. Abraham, M. H., Chadha, H. S., Martins, F., Mitchell, R. C., Bradbury, M. W., Gratton, J. A. (1999) Hydrogen bonding-Part 46: A review of the correlation and prediction of transport properties by an LFER method: Physicochemical properties, brain penetration and skin permeability. Pestic. Sci. 55: 78-88
2. Agatonovic-Kustrin, S., Beresford, R., Pauzi, A., Yusof, M. (2001) ANN modeling of the penetration across a polydimethylsiloxane membrane from theoretically derived molecular descriptors, J. Pharmaceut. Biomed. Anal. 26: 241-254
3. Balant, L. P., Gex-Fabry, M. (2001) Modelling in preclinical and clinical drug development. In: Testa, B., van de Waterbeemd, H., Folkers, G., Guy, R. (eds) Pharmacokinetic optimization in drug research. Wiley-VCH, Weinheim, Germany, pp 15-32
4. Blakey, G. E., Nestorov, I. A., Arundel, P. A., Aarons, L. J., Rowland, M. (1997) Quantitative structure-pharmacokinetics relationships: I. Development of a whole body physiologically based model to characterize changes in pharmacokinetics across a homologous series of barbiturates in the rat. J. Pharmacokinet. Biopharm. 25: 277-312
5. Davis, A. M., Webborn, P. J. H., Salt, D. W. (2000) Robust assessment of statistical significance in the use of unbound/intrinsic pharmacokinetic parameters in quantitative structure-pharmacokinetic relationships with lipophilicity. Drug Metab. Dispos. 28: 103-106
6. Durnas, C., Mingloi, C., Cusack, B. (1990) Hepatic drug metabolism and aging. Clin. Pharmacokinet. 19: 359-389
7. Egan, W. J., Lauri, G. (2002) Prediction of intestinal permeability. Adv. Drug Deliv. Rev. 54: 273-289
8. Foye, W. O., Lemke, T. L., Williams, D. A. (1995) Principles of medicinal chemistry. 4th edn, Lippincott Williams & Wilkins, pp 948-960
9. Fulton, B., Sorkin, E. M. (1995) Propofol an overview of its pharmacology and a review of its clinical efficacy in intensive care sedation. Drugs 50: 587-767
10. Ghafourian, T., Barzegar-Jalali, M. (2002) Theoretical modeling of oral absorption of barbiturates. Il Farmaco 57: 565-567
11. Ghafourian, T., Fooladi, S. (2001) The effect of structural QSAR parameters on skin penetration. Int. J. Pharm. 217: 1-11
12. Glare, P. A., Walsh, T. D. (1991) Clinical pharmacokinetics of morphine. Ther. Drug Monit. 13: 1-23
13. Gobburu, J. V. S., Shelver, W. H. (1995) Quantitative structure-pharmacokinetic relationships (QSPR) of beta blockers derived using neural networks. J. Pharm. Sci. 84: 862-865
14. Greenblatt, D. J. (1981) Clinical pharmacokinetics of oxazepam and lorazepam. Clin. Pharmacokinet. 6: 89-105
15. Hall, L. H., Kier, L. B. (2001) Issues in representation of molecular structure, the development of molecular connectivity. J. Mol. Graph. Model. 20: 76-83
16. Hirono, S., Nakagome, I., Hirano, H., Yoshii, F., Moriguchi, I. (1994) Non-congeneric structure-pharmacokinetic property correlation studies using fuzzy adaptive least squares: Volume of distribution. Biol. Pharm. Bull. 17: 686-690
17. Kansy, M., Fischer, H., Kratzat, K., Senner, F., Wagner, B., Parrilla, I. (2001) High-throughput artificial membrane permeability studies in early lead discovery and development. In: Testa, B., van de Waterbeemd, H., Folkers, G., Guy, R. (eds) Pharmacokinetic optimization in drug research. Wiley-VCH, Weinheim, Germany, pp 447-464
18. Karalis, V., Tsantili-Kakoulidou, A., Macheras, P. (2002) Multivariate statistics of disposition pharmacokinetic parameters for structurally unrelated drugs used in therapeutics. Pharm. Res. 19: 1827-1834
19. Kennedy, T. (1997) Managing the drug discovery/development interface. Drug Discovery Today 2: 436-444
20. Kier, L. B. (1987) Indexes of molecular shape from chemical graphs. Med. Res. Rev. 7: 417-440
21. Klopman, G., Stefan, L. R., Saiakhov, R. D. (2002) ADME evaluation 2. A computer model for the prediction of intestinal absorption in humans. Eur. J. Pharm. Sci. 17: 253-263
22. Kulkarni, A., Han, Y., Hopfinger, A. J. (2002) Predicting Caco-2 cell permeation coefficients of organic molecules using membrane-interaction QSAR analysis. J. Chem. Inf. Comput. Sci. 42: 331-342
23. Lam, Y. W., Banerji S., Hatfield, C., Talbert, L. (1997) Principle of drug administration in renal insufficiency. Clin. Pharmacokinet. 32: 30-57
24. Lipinski, C. A., Lombardo, F., Dominy, B. W., Feeney, P. J. (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23: 3-25
25. Lombardo, F., Obach, R. S., Shalaeva, M. Y., Gao, F. (2002) Prediction of volume of distribution values in humans for neural and basic drugs using physicochemical measurements and plasma protein binding data. J. Med. Chem. 45: 2867-2876
26. Mahmood, I. (1998) Interspecies scaling: Predicting volumes, mean residence time and elimination half-life. Some suggestions. J. Pharm. Pharmacol. 50: 493-499
27. Moffat, A. C., Jackson, J. V., Moss, M. S., Winddop, B. (1986) Clarke's isolation of drug in pharmaceuticals, body fluids, and post-mortem material. 2nd edn, The Pharmaceutical Press, London, pp 309-1060
28. Moss, G. P., Dearden, J. C., Patel, H., Cronin, M. T. D. (2002) Quantitative structure-permeability relationships (QSPRs) for percutaneous absorption. Toxicol. In Vitro 16: 299-317
29. Nattell, S., Gagne, G., Pineau, M. (1987) The pharmacokinetics of lidocaine and β-adrenoreceptor antagonists in patients with acute myocardial infarction. Clin. Pharmacokinet. 13: 293-316
30. Obach, R. S., Baxter, J. G., Liston, T. E., Silber, B. M., Jones, B. C., MacIntyre, F., Rance, D. J., Wastall, P. (1997) The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data. J. Pharmacol. Exp. Ther. 283: 46-58
31. Oie, S., Tozer, T. N. (1979) Effect of altered plasma protein binding on apparent volume of distribution. J. Pharm. Sci. 68: 1203-1205
32. Palm, K., Stenberg, P., Luthman, K., Arturson, P. (1997) Polar molecular surface properties predict the intestinal absorption of drugs in humans. Pharm. Res. 14: 568-571
33. Perry, P. J (2002) Psychotropic agents. In: Schoenwald, R. D. (ed.) Pharmacokinetics in drug discovery and development. CRC Press, Boca Raton, FL, pp 175-197
34. Potter, W. Z., Hollister, L. E. (2001) Antidepressant agents, In: Katzung, B. G. (ed.) Basic & clinical pharmacology. 8th edn, Lang Medical Books/McGraw-Hill, New York, p. 502
35. Raaflaub, V. J., Speiser-Courvoisier, J. (1974) Zur pharmakokinetik von bromazepam beim menschen. Arzneimittelforschung 24: 1841-1844
36. Raevsky, O. A., Schaper, K. J., Artursson, P., McFarland, J. W. (2002) A novel approach for prediction of intestinal absorption of drugs in humans based on hydrogen bond descriptors and structural similarity. Quant. Struct.-Act. Rel. 20: 402-413
37. Ritschel, W. A., Hammer, G. V. (1980) Prediction of the volume of distribution from in vitro data and use for estimating the absolute extent of absorption. Int. J. Clin. Pharmacol. Ther. Toxicol. 18: 298-316
38. Ritschel, W. A., Akileswaran, R., Hussain, A. S. (1995) Application of neural networks for the prediction of human pharmacokinetic parameters. Methods Find. Exp. Clin. Pharmacol. 17: 629-643
39. Rowland, M., Tozer, T. N. (1995) Clinical pharmacokinetics. Concepts and applications. 3rd edn, Lippincott, Williams and Wilkins, Philadelphia, pp 143-155
40. Schoerlin, M., Horber, F. F., Ferry, F. J., Mayersohn, M. (1990) Disposition kinetics of moclobemide, a new MAO-A inhibitor in subjects with impaired renal function. J. Clin. Pharmacol. 30: 272-284
41. Shargel, L., Yu, A. B. C. (1999) Applied biopharmaceutics and pharmacokinetics. Appleton & Lange, Stamford, pp 267-269
42. Sonne, J., Loft, S., Dosing, M., Vollmerlarsen, A., Olesen, K. L., Victor, M., Andreasen, F., Andreasen, P. B. (1988) Bioavailability and pharmacokinetics of oxazepam. Eur. J. Clin. Pharmacol. 35: 385-389
43. Tantishaiyakul, V. (2001) Prediction of Caco-2 cell permeability using partial least squares multivariate analysis. Pharmazie 56: 407-411
44. Thummel, K. E., Shen, D. D. (2001) Design and optimization of dosage regimens: Pharmacokinetic data. In: Hardman, J. G., Limbird, L. E., Gillman, A. G. (eds) Goodman & Gillman's the pharmacological basis of therapeutics. 10th edn, McGraw-Hill, New York, pp 1917-2024
45. Turner, J. V., Maddalena, D. J., Cutler, D. J., Agatonovic-Kustrin, S. (2003) Multiple pharmacokinetic parameter prediction for a series of cephalosporins. J. Pharm. Sci. 92: 552-559
46. Van de Waterbeemd, H. (2002) High-throughput and in silico techniques in drug metabolism and pharmacokinetics. Curr. Opin. Drug Dis. Dev. 5: 33-43
47. Van de Waterbeemed, H., Smith, D. A., Jones, B. C. (2001) Lipophilicity in PK design: Methyl, ethyl, futile. J. Comput. Aided Mol. Des. 15: 273-286
48. Van der Graaf, P. H., Nilsson, J., Van Schaick, E. A., Danhof, M. (1999) Multivariate quantitative structure-pharmacokinetic relationships (QSPKR) analysis of adenosine A1 receptor agonists in rat. J. Pharm. Sci. 88: 306-312
49. Wilkinson, G. R. (2001) Pharmacokinetics: The dynamics of drug absorption, distribution, and elimination. In: Hardman, J. G., Limbird, L. E., Gillman, A. G. (eds) Goodman & Gillman's the pharmacological basis of therapeutics. 10th edn, McGraw-Hill, New York, pp 20-22
50. Zhao, Y. H., Abraham, M. H., Le, J., Hersey, A., Luscombe, C. N., Beck, G., Sherborne, B., Cooper, I. (2002) Rate-limited steps of human oral absorption and QSAR studies. Pharm. Res. 19: 1446-1457